About
PhaseRx develops polymer-based RNA delivery technologies, including SMARTT Polymer Technology, to enable systemic delivery of RNA interference and mRNA therapeutics targeting orphan and inherited liver enzyme deficiency diseases.
Explore PhaseRx, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.